This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

​Pakistan Competition Commission conditionally approves GSK’s purchase of Novartis’ vaccines business

( February 26, 2015, 02:24 GMT | Official Statement) -- MLex Summary: The Competition Commission of Pakistan said it has conditionally approved the proposed acquisition of Novartis' global vaccines business, which doesn’t include the influenza business, by GlaxoSmithKline. GSK and Novartis overlap in the business of MenACWY vaccine, where the two companies sell relevant products under the brand names of Mencevax and Menveo, respectively. The CCP has required GSK to ensure the reliable availability of Menveo in Pakistan and divest its worldwide MenACWY vaccine business to a third-party vaccines supplier.The full statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login